BR112013012598A2 - composição de oligossacarídeos para tratar infecções agudas do trato respiratório - Google Patents
composição de oligossacarídeos para tratar infecções agudas do trato respiratórioInfo
- Publication number
- BR112013012598A2 BR112013012598A2 BR112013012598A BR112013012598A BR112013012598A2 BR 112013012598 A2 BR112013012598 A2 BR 112013012598A2 BR 112013012598 A BR112013012598 A BR 112013012598A BR 112013012598 A BR112013012598 A BR 112013012598A BR 112013012598 A2 BR112013012598 A2 BR 112013012598A2
- Authority
- BR
- Brazil
- Prior art keywords
- respiratory tract
- acute respiratory
- tract infections
- oligosaccharide composition
- treat acute
- Prior art date
Links
- 206010057190 Respiratory tract infections Diseases 0.000 title 1
- 229920001542 oligosaccharide Polymers 0.000 title 1
- 150000002482 oligosaccharides Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10192230A EP2465509A1 (en) | 2010-11-23 | 2010-11-23 | Oligosaccharide composition for treating acute respiratory tract infections |
| PCT/EP2011/070563 WO2012076323A1 (en) | 2010-11-23 | 2011-11-21 | Oligosaccharide composition for treating acute respiratory tract infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013012598A2 true BR112013012598A2 (pt) | 2016-08-09 |
Family
ID=43728675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013012598A BR112013012598A2 (pt) | 2010-11-23 | 2011-11-21 | composição de oligossacarídeos para tratar infecções agudas do trato respiratório |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9763465B2 (pt) |
| EP (2) | EP2465509A1 (pt) |
| CN (1) | CN103582485A (pt) |
| AU (1) | AU2011340882B2 (pt) |
| BR (1) | BR112013012598A2 (pt) |
| CA (1) | CA2818012A1 (pt) |
| CL (1) | CL2013001433A1 (pt) |
| IL (1) | IL226348A0 (pt) |
| MX (1) | MX343321B (pt) |
| RU (1) | RU2593321C2 (pt) |
| SG (1) | SG190323A1 (pt) |
| TW (1) | TW201302205A (pt) |
| WO (1) | WO2012076323A1 (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013016905A2 (pt) | 2010-12-31 | 2019-09-24 | Abbott Lab | métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humano |
| WO2012092153A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
| EP2658548B1 (en) | 2010-12-31 | 2018-02-21 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
| EP3473257A1 (en) | 2010-12-31 | 2019-04-24 | Abbott Laboratories | Methods of using human milk oligosaccharides for improving airway respiratory health |
| MY174542A (en) | 2010-12-31 | 2020-04-24 | Abbott Lab | Human milk oligosaccharides to promote growth of beneficial bacteria |
| SG191799A1 (en) | 2010-12-31 | 2013-08-30 | Abbott Lab | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof |
| MY180910A (en) | 2010-12-31 | 2020-12-11 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
| ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
| CN104023560A (zh) | 2011-08-29 | 2014-09-03 | 雅培制药有限公司 | 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖 |
| EP2745705A1 (en) * | 2012-12-18 | 2014-06-25 | Abbott Laboratories | Nutritional use of human milk oligosaccharides |
| US20150050245A1 (en) * | 2013-08-14 | 2015-02-19 | Tntgamble, Inc. | Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora |
| AU2014350419B2 (en) * | 2013-11-15 | 2019-10-24 | Société des Produits Nestlé S.A. | Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section |
| ES2857077T3 (es) * | 2013-11-15 | 2021-09-28 | Nestle Sa | Composiciones para su uso en la prevención o tratamiento de infecciones del TRS en bebés o niños jóvenes en riesgo |
| MX2017005260A (es) | 2014-10-24 | 2018-01-30 | Evolve Biosystems Inc | Bifidobacterias activadas y metodos de uso de las mismas. |
| RU2720933C2 (ru) * | 2014-10-31 | 2020-05-14 | Сосьете Де Продюи Нестле С.А. | Композиция, содержащая fut2-зависимые олигосахариды и лакто-n-неотетраозу, для применения с целью активации развития головного мозга и познавательной способности |
| US10881674B2 (en) | 2014-12-08 | 2021-01-05 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| EP3229812A4 (en) | 2014-12-08 | 2018-10-03 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| US10835544B2 (en) | 2014-12-08 | 2020-11-17 | Glycom A/S | Synthetic composition for regulating satiety |
| US10987368B2 (en) | 2014-12-08 | 2021-04-27 | Glycom A/S | Synthetic composition for preventing or treating CVD |
| RU2020107846A (ru) * | 2015-03-05 | 2020-03-16 | Сосьете Де Продюи Нестле С.А. | Композиции для применения в профилактике или лечении отита или бронхита у младенцев или детей младшего возраста |
| CN107405354A (zh) * | 2015-03-05 | 2017-11-28 | 格礼卡姆股份公司 | 治疗急性呼吸道感染的组合物和方法 |
| MX2017010923A (es) * | 2015-03-05 | 2018-01-16 | Nestec Sa | Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños. |
| US11957148B2 (en) * | 2015-12-15 | 2024-04-16 | Societe Des Produits Nestle S.A. | Mixture of human milk oligosaccharides(HMOs) |
| CN105725216A (zh) * | 2016-03-15 | 2016-07-06 | 天津普生源科技发展有限公司 | 一种含有gaba的助眠功能食品及其制备方法 |
| WO2018020473A1 (en) | 2016-07-28 | 2018-02-01 | Fonterra Co-Operative Group Limited | Dairy product and process |
| AU2017324759B2 (en) * | 2016-09-07 | 2022-07-28 | Société des Produits Nestlé S.A. | Nutritional compositions for infants and/or young children comprising oligosaccharides |
| EP3629767A1 (en) | 2017-05-24 | 2020-04-08 | Société des Produits Nestlé S.A. | Hmos blends for use in infants or young children for health purposes |
| CN109043542A (zh) * | 2018-09-11 | 2018-12-21 | 内蒙古伊利实业集团股份有限公司 | 人乳寡糖和/或其前体在制备预防儿童龋齿疾病的组合物中的应用 |
| CN113423288A (zh) * | 2019-02-04 | 2021-09-21 | N·V·努特里奇亚 | 用于睡眠改善的含有不可消化的低聚糖的发酵配方物 |
| CN113924101A (zh) * | 2019-04-09 | 2022-01-11 | 因特因思克医药物公司 | 用于治疗疼痛的免疫调节寡糖 |
| JP2021112165A (ja) * | 2020-01-20 | 2021-08-05 | 森永乳業株式会社 | 組成物並びに飲食品組成物、栄養組成物および調製乳 |
| WO2022226311A1 (en) * | 2021-04-23 | 2022-10-27 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function |
| WO2023118197A1 (en) * | 2021-12-20 | 2023-06-29 | Société des Produits Nestlé S.A. | Secretory iga-biotic complexes and uses thereof |
| JP2024004736A (ja) * | 2022-06-29 | 2024-01-17 | 雪印メグミルク株式会社 | 気管支炎を予防するための栄養組成物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991016449A1 (en) | 1990-04-16 | 1991-10-31 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US6045854A (en) * | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
| EP1062873A1 (en) * | 1999-12-13 | 2000-12-27 | N.V. Nutricia | Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate |
| US6630452B2 (en) * | 2000-02-17 | 2003-10-07 | Wyeth | Nutritional formulation containing prebiotic substances |
| ATE503007T1 (de) * | 2003-11-19 | 2011-04-15 | Nestec Sa | Isolierte bakteriophage und ihre verwendung in lebensmitteln oder zur sanierung der fabrik- umgebung |
| MXPA06006392A (es) * | 2003-12-05 | 2007-03-15 | Childrens Hosp Medical Center | Composiciones de oligosacaridos y uso de estas en el tratamiento de infecciones. |
| EP1629850B2 (en) * | 2004-08-24 | 2013-05-22 | N.V. Nutricia | Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides |
| RU2445361C2 (ru) * | 2006-06-13 | 2012-03-20 | Нестек С.А. | Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий |
| EP2044851A1 (en) | 2007-09-26 | 2009-04-08 | Nestec S.A. | Prevention of allergy at weaning |
| WO2009060073A1 (en) * | 2007-11-08 | 2009-05-14 | Nestec S.A. | Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates |
| EP2060257A1 (en) * | 2007-11-08 | 2009-05-20 | Nestec S.A. | Prevention and treatment of secondary infections following viral infection |
| EP2072052A1 (en) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
| EP2813230A1 (en) * | 2009-07-15 | 2014-12-17 | N.V. Nutricia | Fucosyllactose as breast milk identical non-digestible oligosaccharide for treating and/or preventing infections |
| EP2454948A1 (en) * | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
| EP2465507A1 (en) * | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating skin diseases |
| EP2465508A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases |
-
2010
- 2010-11-23 EP EP10192230A patent/EP2465509A1/en not_active Withdrawn
-
2011
- 2011-11-21 SG SG2013038179A patent/SG190323A1/en unknown
- 2011-11-21 WO PCT/EP2011/070563 patent/WO2012076323A1/en active Application Filing
- 2011-11-21 RU RU2013128570/15A patent/RU2593321C2/ru active
- 2011-11-21 EP EP11784695.6A patent/EP2643006A1/en not_active Withdrawn
- 2011-11-21 CA CA2818012A patent/CA2818012A1/en not_active Abandoned
- 2011-11-21 US US13/988,975 patent/US9763465B2/en active Active
- 2011-11-21 MX MX2013005727A patent/MX343321B/es active IP Right Grant
- 2011-11-21 BR BR112013012598A patent/BR112013012598A2/pt not_active IP Right Cessation
- 2011-11-21 CN CN201180056475.7A patent/CN103582485A/zh active Pending
- 2011-11-21 AU AU2011340882A patent/AU2011340882B2/en active Active
- 2011-11-23 TW TW100142957A patent/TW201302205A/zh unknown
-
2013
- 2013-05-13 IL IL226348A patent/IL226348A0/en unknown
- 2013-05-17 CL CL2013001433A patent/CL2013001433A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013128570A (ru) | 2014-12-27 |
| CL2013001433A1 (es) | 2013-12-13 |
| EP2465509A1 (en) | 2012-06-20 |
| IL226348A0 (en) | 2013-07-31 |
| SG190323A1 (en) | 2013-06-28 |
| US9763465B2 (en) | 2017-09-19 |
| EP2643006A1 (en) | 2013-10-02 |
| MX343321B (es) | 2016-11-01 |
| CA2818012A1 (en) | 2012-06-14 |
| TW201302205A (zh) | 2013-01-16 |
| AU2011340882B2 (en) | 2016-10-20 |
| US20130236424A1 (en) | 2013-09-12 |
| RU2593321C2 (ru) | 2016-08-10 |
| MX2013005727A (es) | 2013-07-03 |
| CN103582485A (zh) | 2014-02-12 |
| WO2012076323A1 (en) | 2012-06-14 |
| AU2011340882A1 (en) | 2013-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013012598A2 (pt) | composição de oligossacarídeos para tratar infecções agudas do trato respiratório | |
| NL301016I2 (nl) | Combinatie van daunorubicine en cytarabine | |
| BR112013011730A2 (pt) | composição de oligossacarídeos para tratar doenças da pele | |
| BR112013012998A2 (pt) | compostos para tratar infecções por vírus sincicial respiratório | |
| BRPI0915476A2 (pt) | dispositivo para tratar problemas respiratórios | |
| ES2898695T8 (es) | Derivados de benzoxaborol para el tratamiento de infecciones bacterianas | |
| BRPI1013065A2 (pt) | artigo para fumar com elemento de restrição de fluxo aperfeiçoado | |
| BR112013014614A2 (pt) | misturas de glicosídeo | |
| BRPI1008598A2 (pt) | composição farmacêutica para inalação | |
| ES2855159T8 (es) | Tratamiento de las infecciones pulmonares mediante administración de tobramicina por aerolización | |
| BR112012004080A2 (pt) | composições farmacêuticas para tratar ibd | |
| BR302012002584S1 (pt) | Configuracao aplicada em inalador | |
| SMT201600059B (it) | Trattamento di infezioni da streptococco | |
| BR112014001015A2 (pt) | agente de cura para composições de cura por umidade | |
| BR112012008959A2 (pt) | tratamento de terapia de combinação para infecções virais | |
| SMT201500005B (it) | Composizione framaceutica inalabile | |
| BR112012028007A2 (pt) | composição aquosa | |
| IL221320A0 (en) | Compounds for treating respiratory syncytial virus infections | |
| BR112013014915A2 (pt) | composição curativa e métodos de tratamento | |
| CL2013001313A1 (es) | Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales | |
| BR112013003275A2 (pt) | composição de tratamento oral | |
| BR112012000101A2 (pt) | carboidratos medicinais para tratamento de condições respiratórias | |
| BR112013025744A2 (pt) | composicões para tratamento da doença de raynaud | |
| BR112013015048A2 (pt) | composição para o tratamento de distúrbios metabólicos | |
| BR112012029461A2 (pt) | composição farmacêutica contendo solifenacina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A23L 33/00 (2016.01), A61P 11/00 (2006.01), A61P 2 |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |